CycloLab partner organization in BactiVax project

News 17 December, 2019
The kick-off meeting of Marie- Skłodowska-Curie Innovative Training Network “BactiVax” within the Horizon 2020 Programme of the European Commission was held in the last week.
BactiVax (anti-Bacterial Innovative Vaccines) is an innovative European Training Network that will provide high-level training in vaccinology to 15 high-achieving, creative Early Stage Researchers (ESRs), and equip them with a wide range of transferrable skills for thriving careers in vaccine research within academia and industry. BactiVax will focus on developing novel vaccines to tackle the huge challenge of antimicrobial-resistant human pathogens that cause chronic, life-threatening respiratory and/or systemic infections. This network comprises 14 Principal Investigators with expertise in vaccinology, proteomics, medicine, microbiology, biochemistry, immunology, structural biology, medicinal, peptide and glycochemistry from 8 European countries and two companies which will collectively train ESRs in entrepreneurship, commercial vaccine development and bioprocessing.

CycloLab together with Pfizer, ImmunXperts and other companies will participate as a partner organization providing training possibilities for the students in a secondment.
Details :